{"entity":{"type":"insider","cik":"0001532357","url":"/insider/0001532357","json_url":"/insider/0001532357.json","name":"Carrazana Enrique J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2012-10-18","last":"2015-12-03","span_basis":"filed_date"},"name_variants":[{"name":"Carrazana Enrique J.","source":"filing","n_filings":8,"first_seen":"2012-10-18","last_seen":"2015-12-03"}],"transactions":[{"id":8775180,"accession":"0001209191-15-083221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083221","line_url":"/filing/0001209191-15-083221#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7218.0,"shares_display":"7,218","price_per_share":38.081,"price_display":"38.08","price_state":"stated","total_value":274868.658,"total_display":"274,868.66","total_whole":"274,869","shares_owned_after":32148.0,"shares_owned_after_display":"32,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8180720,"accession":"0001209191-15-003808","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-003808","line_url":"/filing/0001209191-15-003808","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13371.0,"shares_display":"13,371","price_per_share":42.955748223767856,"price_display":"42.96","price_state":"stated","total_value":574361.3095,"total_display":"574,361.31","total_whole":"574,361","shares_owned_after":38665.0,"shares_owned_after_display":"38,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-12","scope":"insider","n_lines":2},{"id":8180711,"accession":"0001209191-15-003808","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-003808","line_url":"/filing/0001209191-15-003808#line-6","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77907.0,"shares_display":"77,907","price_per_share":42.1058,"price_display":"42.11","price_state":"stated","total_value":3280336.5606,"total_display":"3,280,336.56","total_whole":"3,280,337","shares_owned_after":33494.0,"shares_owned_after_display":"33,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-12","scope":"insider"},{"id":8180701,"accession":"0001209191-15-003808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003808","line_url":"/filing/0001209191-15-003808#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6715.0,"shares_display":"6,715","price_per_share":42.0058,"price_display":"42.01","price_state":"stated","total_value":282068.947,"total_display":"282,068.95","total_whole":"282,069","shares_owned_after":33494.0,"shares_owned_after_display":"33,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":6680498,"accession":"0001209191-14-072919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072919","line_url":"/filing/0001209191-14-072919#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":35.5538,"price_display":"35.55","price_state":"stated","total_value":81773.74,"total_display":"81,773.74","total_whole":"81,774","shares_owned_after":33494.0,"shares_owned_after_display":"33,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6448410,"accession":"0001209191-14-063804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-063804","line_url":"/filing/0001209191-14-063804","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":30.890594239423944,"price_display":"30.89","price_state":"stated","total_value":102958.3506,"total_display":"102,958.35","total_whole":"102,958","shares_owned_after":36727.0,"shares_owned_after_display":"36,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-17","scope":"insider","n_lines":2},{"id":4758355,"accession":"0001209191-13-055273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055273","line_url":"/filing/0001209191-13-055273#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1640.0,"shares_display":"1,640","price_per_share":33.5574,"price_display":"33.56","price_state":"stated","total_value":55034.136,"total_display":"55,034.14","total_whole":"55,034","shares_owned_after":32527.0,"shares_owned_after_display":"32,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4426611,"accession":"0001209191-13-048608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-048608","line_url":"/filing/0001209191-13-048608#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":32.3785,"price_display":"32.38","price_state":"stated","total_value":107917.5405,"total_display":"107,917.54","total_whole":"107,918","shares_owned_after":34167.0,"shares_owned_after_display":"34,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":2165037,"accession":"0001209191-12-055894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055894","line_url":"/filing/0001209191-12-055894#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":19600.0,"total_display":"19,600.00","total_whole":"19,600","shares_owned_after":29200.0,"shares_owned_after_display":"29,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":2991195,"accession":"0001209191-12-049858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-049858","line_url":"/filing/0001209191-12-049858#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001532357","owner_name":"Carrazana Enrique J.","owner_display_name":"Carrazana Enrique J.","owner_url":"/insider/0001532357","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":23.55,"price_display":"23.55","price_state":"stated","total_value":73005.0,"total_display":"73,005.00","total_whole":"73,005","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (Chief Medical Officer)","n_filings":8,"first_seen":"2012-10-18","last_seen":"2015-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532357","retrieved_at":"2026-08-24T07:43:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}